SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

Clinical trial NCT06435403 · UNKNOWN

Trial details

NCT number: NCT06435403
Sponsor: Michael Hoelscher
Status: UNKNOWN
Study type: OBSERVATIONAL

SARS CoV 2 Infection COVID-19 Breakthrough COVID-19 Recurrent

Start date: 2022-11-10
Primary completion: 2025-02-28
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.